Oppositely, retromer stabilization using the pharmacological chaperone TPT-172 (R33) can reduce Aβ deposition and abnormal tau, and improve memory impairments in the 3xTg mouse model of AD [46]. The gene discussed is MAPT; the disease is Alzheimer disease.